GlassScriptPhysician profile
Urmil R Gupta
NPI 1245331057
$601.32
in general payments reported to CMS, 2019-2025
9 companies · none reported in 2025
See the full distribution for Geriatric Medicine (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $257 · 2020: $200 · 2021: $115 · 2022: $29.67.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $183.39 | 2019-2020 | |
| Glaxosmithkline, LLC. | $112.52 | 2019-2021 | |
| Regeneron Healthcare Solutions, INC. | $82.38 | 2020-2021 | |
| Genzyme Corporation | $51.35 | 2020-2022 | |
| Jazz Pharmaceuticals INC. | $50.42 | 2019-2020 | |
| Indivior INC. | $48.16 | 2019-2021 | |
| Circassia INC. | $29.46 | 2019-2020 | |
| Mylan Specialty L.P. | $28.90 | 2021 | |
| Orexo US, INC. | $14.74 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Urmil Gupta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.